Enfusion rose over 20% after itopened at $20 above $17 IPO price.Enfusion is a global fast-growing SaaS provider, focusing on the transformation of the investment management industry. The company aims to remove technical and information barriers and enable investment managers to confidently make and execute smarter investment decisions in real time. In 2019-2020, the company's revenues were US $59.03 million and US $79.57 million respectively, and the corresponding net profits were US $12.66 million and US $4.06 million respectively.
精彩评论